MENU
+Compare
MESO
Stock ticker: NASDAQ
AS OF
Dec 23, 04:59 PM (EDT)
Price
$17.38
Change
+$2.75 (+18.80%)
Capitalization
1.71B

MESO Mesoblast Limited Forecast, Technical & Fundamental Analysis

a company, which engages in the development and commercialization of biological products

Industry Biotechnology
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for MESO with price predictions
Dec 20, 2024

MESO saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for MESO moved out of overbought territory on December 20, 2024. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 58 similar instances where the indicator exited the overbought zone. In of the 58 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MESO moved out of overbought territory on December 20, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MESO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MESO broke above its upper Bollinger Band on December 19, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 13, 2024. You may want to consider a long position or call options on MESO as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MESO just turned positive on December 17, 2024. Looking at past instances where MESO's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MESO advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 139 cases where MESO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MESO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.476) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). MESO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (140.845) is also within normal values, averaging (256.215).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MESO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MESO is expected to report earnings to rise 29.23% to -17 cents per share on February 28

Mesoblast Limited MESO Stock Earnings Reports
Q4'23
Est.
$-0.17
Q3'23
Missed
by $0.01
Q2'23
Beat
by $0.28
Q1'23
Beat
by $0.14
Q4'22
Beat
by $0.02
The last earnings report on November 22 showed earnings per share of -13 cents, missing the estimate of -12 cents. With 617.61K shares outstanding, the current market capitalization sits at 1.71B.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of biological products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Level 38, 55 Collins Street
Phone
+61 396396036
Employees
83
Web
https://www.mesoblast.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
REIIX13.770.22
+1.62%
West Loop Realty Instl
POAGX44.410.53
+1.21%
PRIMECAP Odyssey Aggressive Growth
GMNPX38.360.44
+1.16%
Goldman Sachs MLP Energy Infras P
ANTGX8.000.04
+0.50%
American Century Non-US Intrs Val G
MGFNX8.930.02
+0.22%
MassMutual Global R3

MESO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been closely correlated with SAGE. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if MESO jumps, then SAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
-12.71%
SAGE - MESO
66%
Closely correlated
+12.20%
QTTB - MESO
52%
Loosely correlated
+7.49%
VTGN - MESO
48%
Loosely correlated
+11.11%
TNGX - MESO
33%
Poorly correlated
+5.44%
TSVT - MESO
32%
Poorly correlated
+7.53%
More